Invivyd
Latest round
- Series C
Last raised
- Apr 2021
Total raised
- $466M
Investors
- 15
About Invivyd
Based in Massachusetts, US, and founded in 2020, Invivyd, Inc. (NASDAQ:IVVD), formerly known as Adagio Therapeutics, Inc. is a biotech that develops antibodies to treat or prevent Covid-19. The company was co-founded by Laura Walker and Tillman Gerngross (CEO). The company is listed on the Nasdaq under the symbol ADGI. As of 2021, the company employs 68 people. Adagio Therapeutics, Inc. offers antibodies intended to neutralize and provide treatment for emergent coronaviruses, including SARS-CoV-2, SARS-CoV-1, and other related coronaviruses. The company also focuses on phase 1 study of ADG20 (a highly potent and broad mAb therapeutic candidate for both the treatment and prevention of COVID-19), a pivotal phase 1/2/3 clinical trial in high-risk individuals with mild or moderate COVID-19. Adagio Therapeutics, Inc.
Who invested in Invivyd
15 investors across 3 rounds
See all investors in Invivyd
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Invivyd
Who invested in Invivyd?
Invivyd has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Invivyd raised?
Invivyd has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Invivyd last raise money?
Invivyd's most recent round on record is a Series C, in Apr 2021.
What does Invivyd do?
Based in Massachusetts, US, and founded in 2020, Invivyd, Inc.
Where is Invivyd headquartered?
Invivyd is headquartered in Waltham, US.
Which VCs invest in companies like Invivyd?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Invivyd's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Invivyd? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.